Publication | Open Access

PEGylated Elesclomol@Cu(Ⅱ)-based Metal‒organic framework with effective nanozyme performance and cuproptosis induction efficacy for enhanced PD-L1-based immunotherapy

NanomedicineNanotherapeuticsEngineeringTherapeutic NanomaterialsImmunologyNano-drug DeliveryImmunotherapeuticsCuproptosis Induction EfficacyBiomedical EngineeringMetal‒organic FrameworkEnhanced Pd-l1-based ImmunotherapyImmunotherapyMedicineTumor TargetingBiomolecular Engineering